Central apelin controls glucose homeostasis via a nitric oxide-dependent pathway in mice

Antioxidants and Redox Signaling

Volumn 15, Issue 6, 2011, Pages 1477-1496

  Duparc, Thibaut ^a,b   Colom, André ^a,b   Cani, Patrice D ^c   Massaly, Nicolas ^d   Rastrelli, Sophie ^a,b   Drougard, Anne ^a,b   Le Gonidec, Sophie ^a   Moulédous, Lionel ^e   Frances, Bernard ^d   Leclercq, Isabelle ^c   Llorens Cortes, Catherine ^f   Pospisilik, J Andrew ^g   Delzenne, Nathalie M ^c   Valet, Philippe ^a,b   Castan Laurell, Isabelle ^a,b   Knauf, Claude ^a,b  

^a INSERM   (France)

^b University Hospital of Toulouse   (France)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^d UNIVERSITÉ DE TOULOUSE   (France)

^e INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^f l'alimentation et l'Environnement   (France)

^g MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APELIN; N(G) METHYLARGININE; NITRIC OXIDE; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD GLUCOSE MONITORING; CIRCADIAN RHYTHM; CONTROLLED STUDY; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPOTHALAMUS; INSULIN RESISTANCE; LIPID DIET; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BIOSYNTHETIC PATHWAYS; BRAIN; CIRCADIAN RHYTHM; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; GLUCOSE; HOMEOSTASIS; HUMANS; HYPOTHALAMUS; INFUSIONS, INTRAVENTRICULAR; INSULIN; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NEURONS; NITRIC OXIDE;

MUS;

EID: 79961191336     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3454     Document Type: Article

References (50)

1. Ahima RS and Osei SY. Adipokines in obesity. Front Horm Res 36: 182-197, 2008.
2. Becskei C, Lutz TA, and Riediger T. Diet-derived nutrients mediate the inhibition of hypothalamic NPY neurons in the arcuate nucleus of mice during refeeding. Am J Physiol Regul Integr Comp Physiol 297: R100-110, 2009.
3. Boucher J, Masri B, Daviaud D, Gesta S, Guigne C, Mazzucotelli A, Castan-Laurell I, Tack I, Knibiehler B, Carpene C, Audigier Y, Saulnier-Blache JS, and Valet P. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146: 1764-1771, 2005. (Pubitemid 40396885)
4. Burcelin R, Cani PD, and Knauf C. Glucagon-like peptide-1 and energy homeostasis. J Nutr 137: 2534S-2538S, 2007. (Pubitemid 350058731)
5. Cabou C, Campistron G, Marsollier N, Leloup C, Cruciani-Guglielmacci C, Penicaud L, Drucker DJ, Magnan C, and Burcelin R. Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity. Diabetes 57: 2577-2587, 2008.
6. Cabou C, Cani PD, Campistron G, Knauf C, Mathieu C, Sartori C, Amar J, Scherrer U, and Burcelin R. Central insulin regulates heart rate and arterial blood flow: An endothelial nitric oxide synthase-dependent mechanism altered during diabetes. Diabetes 56: 2872-2877, 2007. (Pubitemid 350223620)
7. Carpene C, Dray C, Attane C, Valet P, Portillo MP, Churruca I, Milagro FI, and Castan-Laurell I. Expanding role for the apelin/APJ system in physiopathology. J Physiol Biochem 63: 359-373, 2007.
8. Clarke KJ, Whitaker KW, and Reyes TM. Diminished metabolic responses to centrally-administered apelin-13 in dietinduced obese rats fed a high-fat diet. J Neuroendocrinol 21: 83-89, 2009.
9. Corssmit EP, Romijn JA, and Sauerwein HP. Review article: Regulation of glucose production with special attention to nonclassical regulatory mechanisms: A review. Metabolism 50: 742-755, 2001. (Pubitemid 32700451)
10. De Mota N, Lenkei Z, and Llorens-Cortes C. Cloning, pharmacological characterization and brain distribution of the rat apelin receptor. Neuroendocrinology 72: 400-407, 2000. (Pubitemid 32037653)
11. De Mota N, Reaux-Le Goazigo A, El Messari S, Chartrel N, Roesch D, Dujardin C, Kordon C, Vaudry H, Moos F, and Llorens-Cortes C. Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc Natl Acad Sci USA 101: 10464-10469, 2004. (Pubitemid 38924948)
12. Dray C, Knauf C, Daviaud D, Waget A, Boucher J, Buleon M, Cani PD, Attane C, Guigne C, Carpene C, Burcelin R, Castan-Laurell I, and Valet P. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab 8: 437-445, 2008.
13. Duparc T, Naslain D, Colom AX, Muccioli GG, Massaly N, Delzenne NM, Valet P, Cani PD, and Knauf C. Jejunum inflammation in obese and diabetic mice impairs enteric glucose detection and modifies nitric oxide release in the hypothalamus. Antioxid Redox Signal 14: 415-423, 2011.
14. Erdem G, Dogru T, Tasci I, Sonmez A, and Tapan S. Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 116: 289-292, 2008. (Pubitemid 351798738)
15. Faletti AG, Mastronardi CA, Lomniczi A, Seilicovich A, Gimeno M, McCann SM, and Rettori V. beta-Endorphin blocks luteinizing hormone-releasing hormone release by inhibiting the nitricoxidergic pathway controlling its release. Proc Natl Acad Sci USA 96: 1722-1726, 1999. (Pubitemid 29098518)
16. Fioramonti X, Marsollier N, Song Z, Fakira KA, Patel RM, Brown S, Duparc T, Pica-Mendez A, Sanders NM, Knauf C, Valet P, McCrimmon RJ, Beuve A, Magnan C, and Routh VH. Ventromedial hypothalamic nitric oxide production is necessary for hypoglycemia detection and counterregulation. Diabetes 59: 519-528, 2010.
17. Frier BC, Williams DB, and Wright DC. The effects of apelin treatment on skeletal muscle mitochondrial content. Am J Physiol Regul Integr Comp Physiol 297: R1761-1768, 2009.
18. Heinonen MV, Purhonen AK, Miettinen P, Paakkonen M, Pirinen E, Alhava E, Akerman K, and Herzig KH. Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding. Regul Pept 130: 7-13, 2005. (Pubitemid 40966016)
19. Higuchi K, Masaki T, Gotoh K, Chiba S, Katsuragi I, Tanaka K, Kakuma T, and Yoshimatsu H. Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice. Endocrinology 148: 2690-2697, 2007. (Pubitemid 46984786)
20. Jaimes EA, Sweeney C, and Raij L. Effects of the reactive oxygen species hydrogen peroxide and hypochlorite on en-dothelial nitric oxide production. Hypertension 38: 877-883, 2001. (Pubitemid 34258686)
21. Knauf C, Cani PD, Ait-Belgnaoui A, Benani A, Dray C, Cabou C, Colom A, Uldry M, Rastrelli S, Sabatier E, Godet N, Waget A, Penicaud L, Valet P, and Burcelin R. Brain glucagon-like peptide 1 signaling controls the onset of highfat diet-induced insulin resistance and reduces energy expenditure. Endocrinology 149: 4768-4777, 2008.
22. Knauf C, Cani PD, Kim DH, Iglesias MA, Chabo C, Waget A, Colom A, Rastrelli S, Delzenne NM, Drucker DJ, Seeley RJ, and Burcelin R. Role of central nervous system glucagonlike peptide-1 receptors in enteric glucose sensing. Diabetes 57: 2603-2612, 2008.
23. Knauf C, Cani PD, Perrin C, Iglesias MA, Maury JF, Bernard E, Benhamed F, Gremeaux T, Drucker DJ, Kahn CR, Girard J, Tanti JF, Delzenne NM, Postic C, and Burcelin R. Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. J Clin Invest 115: 3554-3563, 2005. (Pubitemid 43121843)
24. Knauf C, Prevot V, Stefano GB, Mortreux G, Beauvillain JC, and Croix D. Evidence for a spontaneous nitric oxide release from the rat median eminence: Influence on gonadotropinreleasing hormone release. Endocrinology 142: 2343-2350, 2001. (Pubitemid 32473089)
25. Kosior-Korzecka U and Bobowiec R. Leptin effect on nitric oxide and GnRH-induced FSH secretion from ovine pituitary cells in vitro. J Physiol Pharmacol 57: 637-647, 2006. (Pubitemid 46096110)
26. Lam TK, Schwartz GJ, and Rossetti L. Hypothalamic sensing of fatty acids. Nat Neurosci 8: 579-584, 2005. (Pubitemid 40594197)
27. Marsollier N, Kassis N, Mezghenna K, Soty M, Fioramonti X, Lacombe A, Joly A, Pillot B, Zitoun C, Vilar J, Mithieux G, Gross R, Lajoix AD, Routh V, Magnan C, and Cruciani-Guglielmacci C. Deregulation of hepatic insulin sensitivity induced by central lipid infusion in rats is mediated by nitric oxide. PLoS One 4: e6649, 2009.
28. Maury E and Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 314: 1-16, 2010.
29. McCann SM, Mastronardi C, de Laurentiis A, and Rettori V. The nitric oxide theory of aging revisited. Ann NY Acad Sci 1057: 64-84, 2005. (Pubitemid 43211628)
30. Munzberg H and Myers MG, Jr. Molecular and anatomical determinants of central leptin resistance. Nat Neurosci 8: 566-570, 2005. (Pubitemid 40594195)
31. Perrin C, Knauf C, and Burcelin R. Intracerebroventricular infusion of glucose, insulin, and the adenosine monophosphate-activated kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, controls muscle glycogen synthesis. Endocrinology 145: 4025-4033, 2004. (Pubitemid 39120547)
32. Reaux A, De Mota N, Skultetyova I, Lenkei Z, El Messari S, Gallatz K, Corvol P, Palkovits M, and Llorens-Cortes C. Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J Neurochem 77: 1085-1096, 2001. (Pubitemid 32467063)
33. Reaux A, Gallatz K, Palkovits M, and Llorens-Cortes C. Distribution of apelin-synthesizing neurons in the adult rat brain. Neuroscience 113: 653-662, 2002. (Pubitemid 34874689)
34. Reis WL, Giusti-Paiva A, Ventura RR, Margatho LO, Gomes DA, Elias LL, and Antunes-Rodrigues J. Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats. Exp Physiol 92: 903-911, 2007. (Pubitemid 47283898)
35. Rodríguez EM, Blazquez JL, and Guerra M. The design of barriers in the hypothalamus allows the median eminence and the arcuate nucleus to enjoy private milieus: The former opens to the portal blood and the latter to the cerebrospinal fluid. Peptides 31: 757-776, 2010.
36. Shankar R, Zhu J, Ladd B, Henry D, Shen H, and Baron A. Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action. J Clin Invest 102: 1403-1412, 1998. (Pubitemid 28467569)
37. Shankar RR, Wu Y, Shen HQ, Zhu JS, and Baron AD. Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes 49: 684-687, 2000. (Pubitemid 30339980)
38. Shimazu T. Innervation of the liver and glucoregulation: Roles of the hypothalamus and autonomic nerves. Nutrition 12: 65-66, 1996. (Pubitemid 26082758)
39. Shimazu T and Fujimoto T. Regulation of glycogen metabolism in liver by the autonomic nervous system. IV. Neural control of glycogen biosynthesis. Biochim Biophys Acta 252: 18-27, 1971.
40. Shimazu T and Fukuda A. Increased activities of glycogenolytic enzymes in liver after splanchnic-nerve stimulation. Science 150: 1607-1608, 1965.
41. Shimazu T, Fukuda A, and Ban T. Reciprocal influences of the ventromedial and lateral hypothalamic nuclei on blood glucose level and liver glycogen content. Nature 210: 1178-1179, 1966.
42. Soriguer F, Garrido-Sanchez L, Garcia-Serrano S, Garcia-Almeida JM, Garcia-Arnes J, Tinahones FJ, and Garcia-Fuentes E. Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Obes Surg 19: 1574-1580, 2009.
43. Sunter D, Hewson AK, and Dickson SL. Intracerebroventricular injection of apelin-13 reduces food intake in the rat. Neurosci Lett 353: 1-4, 2003. (Pubitemid 37464605)
44. Taheri S, Murphy K, Cohen M, Sujkovic E, Kennedy A, Dhillo W, Dakin C, Sajedi A, Ghatei M, and Bloom S. The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochem Biophys Res Commun 291: 1208-1212, 2002. (Pubitemid 34694318)
45. Tatemoto K, Takayama K, Zou MX, Kumaki I, Zhang W, Kumano K, and Fujimiya M. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 99: 87-92, 2001. (Pubitemid 32522535)
46. Tiraby C, Tavernier G, Capel F, Mairal A, Crampes F, Rami J, Pujol C, Boutin JA, and Langin D. Resistance to highfat-diet-induced obesity and sexual dimorphism in the metabolic responses of transgenic mice with moderate uncoupling protein 3 overexpression in glycolytic skeletal muscles. Diabetologia 50: 2190-2199, 2007. (Pubitemid 47373849)
47. Valle A, Hoggard N, Adams AC, Roca P, and Speakman JR. Chronic central administration of apelin-13 over 10 days increases food intake, body weight, locomotor activity and body temperature in C57BL/6 mice. J Neuroendocrinol 20: 79-84, 2008. (Pubitemid 350239151)
48. Yi CX, Serlie MJ, Ackermans MT, Foppen E, Buijs RM, Sauerwein HP, Fliers E, and Kalsbeek A. A major role for perifornical orexin neurons in the control of glucose metabolism in rats. Diabetes 58: 1998-2005, 2009.
49. Yue P, Jin H, Aillaud-Manzanera M, Deng AC, Azuma J, Asagami T, Kundu RK, Reaven GM, Quertermous T, and Tsao PS. Apelin is necessary for the maintenance of insulin sensitivity. Am J Physiol Endocrinol Metab 298: E59-67, 2010.
50. Zhong JC, Yu XY, Huang Y, Yung LM, Lau CW, and Lin SG. Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice. Cardiovasc Res 74: 388-395, 2007. (Pubitemid 46693698)